Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|July 25, 2016
Management of ventilator-associated pneumonia in intensive care units: a mixed methods study assessing barriers and facilitators to guideline adherenceNasia Safdar, Jackson S Musuuza, Anping Xie, et al.
Plos One|November 19, 2020
Nasal povidone-iodine implementation for preventing surgical site infections: Perspectives of surgical nursesEric N Hammond, Nicole Brys, Ashley Kates, et al.
Journal of Clinical Medicine Research|February 8, 2024
Cold Agglutinin Disease and COVID-19: A Scoping Review of Treatments and OutcomesJackson S Musuuza, Silpa Kumar, Dheeraj Kumar Posa, et al.
Cancer|April 16, 2013
Analyzing excess mortality from cancer among individuals with mental illnessJackson S Musuuza, Marion E Sherman, Kraig J Knudsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2020
Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysisAnnie S Jasper, Jackson S Musuuza, Jessica S Tischendorf, et al.
BMC Infectious Diseases|May 16, 2019
The impact of chlorhexidine bathing on hospital-acquired bloodstream infections: a systematic review and meta-analysisJackson S Musuuza, Pramod K Guru, John C O'Horo, et al.
American Journal of Infection Control|May 6, 2014
Evaluation of patients' skin, environmental surfaces, and urinary catheters as sources for transmission of urinary pathogensKathleen A Linder, Michelle T Hecker, Sirisha Kundrapu, et al.
Infection Control and Hospital Epidemiology|April 12, 2017
Risk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficileCara M Cannon, Jackson S Musuuza, Anna K Barker, et al.
BMC Infectious Diseases|April 20, 2016
Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?Sirisha Kundrapu, Venkata C K Sunkesula, Lucy A Jury, et al.
Implementation Science Communications|June 2, 2021
Feasibility of a pharmacy-led intervention to de-implement non-guideline-concordant proton pump inhibitor useJackson S Musuuza, Emily Fong, Paul Lata, et al.
Pageof 3